Regulatory Environment for Genome Editing Products
FDA, EMA, and international regulatory frameworks significantly shape the Genome Editing Techniques Market through evolving approval pathways and safety requirements. Gene therapy regulations govern ex vivo edited cell products with extensive characterization requirements. In vivo editing faces unique challenges including off-target assessment, editing persistence, and germline transmission...
0 Comentários 0 Compartilhamentos 15 Visualizações 0 Anterior